SCHEMBL1850274

SCHEMBL1850274

C=C(C)C(=O)OC(C)CCN=C=O

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28400842 0.89 TSHR (0.35) TSHR
SCHEMBL322300 0.83 TSHR (0.40) TSHRALDH1A1
SCHEMBL4099791 0.81 TSHR (0.38) TSHR
SCHEMBL4098257 0.81 TSHR (0.36) TSHRALDH1A1
SCHEMBL28949777 0.80
SCHEMBL2540758 0.80 TSHR (0.50) TSHRALDH1A1
Methacrylic Acid SCHEMBL28204338 0.79 TSHR (0.37) TSHRALDH1A1
SCHEMBL1850146 0.77 TSHR (0.38) TSHRALDH1A1
SCHEMBL5161744 0.75 TSHR (0.31) TSHR
SCHEMBL28979069 0.75 TSHR (0.31) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11891472-B2 Composition, production method for composition, and production method for unsaturated compound RESONAC CORPORATION (JP) 2024-02-06 US disclosed
EP-3842417-B1 COMPOSITION, PRODUCTION METHOD FOR COMPOSITION, AND PRODUCTION METHOD FOR UNSATURATED COMPOUND RESONAC CORP (JP) 2024-01-24 EP disclosed
US-11661474-B2 Composition, production method for composition, and production method for unsaturated compound SHOWA DENKO K.K. (JP) 2023-05-30 US disclosed
EP-3842414-B1 COMPOSITION, PRODUCTION METHOD FOR COMPOSITION, AND PRODUCTION METHOD FOR UNSATURATED COMPOUND SHOWA DENKO KK (JP) 2023-04-05 EP disclosed
CN-112533896-B Composition, method for producing composition, and method for producing unsaturated compound 昭和电工株式会社 2023-03-03 CN disclosed
EP-3842416-B1 COMPOSITION, PRODUCTION METHOD FOR COMPOSITION, AND PRODUCTION METHOD FOR UNSATURATED COMPOUND SHOWA DENKO KK (JP) 2023-03-01 EP disclosed
CN-112533895-B Composition, method for producing composition, and method for producing unsaturated compound 昭和电工株式会社 2023-02-17 CN disclosed
CN-114929668-A (meth) acrylate compound having isocyanate group and method for producing same 昭和电工株式会社 2022-08-19 CN disclosed
US-20220119585-A1 COMPOSITION, PRODUCTION METHOD FOR COMPOSITION, AND PRODUCTION METHOD FOR UNSATURATED COMPOUND SHOWA DENKO K.K. (JP) 2022-04-21 US disclosed
EP-3533813-B1 GEL POLYMER ELECTROLYTE, METHOD FOR PRODUCING GEL POLYMER ELECTROLYTE AND ELECTROCHROMIC DEVICE CONTAINING SAME LG CHEMICAL LTD (KR) 2022-02-09 EP disclosed
EP-2676951-A1 STABILIZED ISOCYANATE GROUP-CONTAINING ETHYLENE-BASED UNSATURATED COMPOUND SHOWA DENKO K.K. (JP) 2013-12-25 EP disclosed
EP-2676950-A1 STABILIZED ISOCYANATE GROUP-CONTAINING ETHYLENE-BASED UNSATURATED COMPOUND SHOWA DENKO K.K. (JP) 2013-12-25 EP disclosed
US-20130317252-A1 STABILIZED ISOCYANATE GROUP-CONTAINING ETHYLENICALLY UNSATURATED COMPOUND SHOWA DENKO K.K. (JP) 2013-11-28 US disclosed
US-20130317248-A1 STABILIZED ISOCYANATE GROUP-CONTAINING ETHYLENICALLY UNSATURATED COMPOUND SHOWA DENKO K.K. (JP) 2013-11-28 US disclosed
US-20120205234-A1 POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION SHOWA DENKO K.K. (JP) 2012-08-16 US disclosed
US-20110137066-A1 PROCESS OF INHIBITING POLYMERIZATION OF ISOCYANATE GROUP-CONTAINING, ETHYLENICALLY UNSATURATED CARBOXYLATE COMPOUNDS, AND PROCESS FOR PRODUCING THE COMPOUNDS SHOWA DENKO K.K. (JP) 2011-06-09 US disclosed
EP-2325166-A1 METHOD FOR INHIBITING POLYMERIZATION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACID ESTER COMPOUND CONTAINING ISOCYANATE GROUP AND METHOD FOR PRODUCING ETHYLENICALLY UNSATURATED CARBOXYLIC ACID ESTER COMPOUND CONTAINING ISOCYANATE GROUP Showa Denko K.K. (JP) 2011-05-25 EP disclosed
US-20100099827-A1 POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION SHOWA DENKO K.K. (JP) 2010-04-22 US disclosed
EP-2091994-A1 POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION Showa Denko K.K. (JP) 2009-08-26 EP disclosed
WO-2008069256-A1 POLYMERIZABLE MONOMER COMPOSITION AND METHOD FOR PREVENTING POLYMERIZATION SHOWA DENKO K.K. (JP) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11661474-B2 Composition, production method for composition, and production method for unsaturated compound ELOVL1, ACOX1, NCOA1 TSHR 3345/4885ALDH1A1 1279/4885
US-20110137066-A1 PROCESS OF INHIBITING POLYMERIZATION OF ISOCYANATE GROUP-CONTAINING, ETHYLENICALLY UNSATURATED CARBOXYLATE COMPOUNDS, AND PROCESS FOR PRODUCING THE COMPOUNDS ALKBH3, OGDH, IDH2 TSHR 4884/4885ALDH1A1 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.